Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Amanda Rao, Elizabeth Steels, Warrick J. Inder, Suzanne Abraham & Luis Vitetta. (2016) Testofen, a specialised Trigonella foenum-graecum seed extract reduces age-related symptoms of androgen decrease, increases testosterone levels and improves sexual function in healthy aging males in a double-blind randomised clinical study. The Aging Male 19:2, pages 134-142.
Read now
Read now
A. Afiadata & Pamela Ellsworth. (2014) Testosterone Replacement Therapy: Who to Evaluate, What to Use, How to Follow, and Who is at Risk?. Hospital Practice 42:5, pages 69-82.
Read now
Read now
Bruno Lunenfeld, Stefan Arver, Ignacio Moncada, D. Aled Rees & Heinrich M. Schulte. (2012) How to help the aging male? Current approaches to hypogonadism in primary care. The Aging Male 15:4, pages 187-197.
Read now
Read now
Ronald Tamler & Tatiana Deveney. (2010) Hypogonadism, Erectile Dysfunction, and Type 2 Diabetes Mellitus: What the Clinician Needs to Know. Postgraduate Medicine 122:6, pages 165-175.
Read now
Read now
Nazem Bassil, Saad Alkaade & John E Morley. (2009) The benefits and risks of testosterone replacement therapy: a review. Therapeutics and Clinical Risk Management 5, pages 427-448.
Read now
Read now
Articles from other publishers (20)
Ryszard Skiba, Aleksandra Rymarz, Anna Matyjek, Jolanta Dymus, Agnieszka Woźniak-Kosek, Tomasz Syryło, Henryk Zieliński & Stanisław Niemczyk. (2022) Testosterone Replacement Therapy in Chronic Kidney Disease Patients. Nutrients 14:16, pages 3444.
Crossref
Crossref
Denys Gibbons, Daniel P. Ahern, Antoinette E. Curley, Christopher K. Kepler & Joseph S. Butler. (2021) Impact of Sarcopenia on Degenerative Lumbar Spondylosis. Clinical Spine Surgery: A Spine Publication 34:2, pages 43-50.
Crossref
Crossref
Mortaza F. Hassanabad & Mohammad Fatehi. (2020) Androgen Therapy in Male Patients Suffering from Type 2 Diabetes: A Review of Benefits and Risks. Current Diabetes Reviews 16:3, pages 189-199.
Crossref
Crossref
Barbara I. Gulanski, Clare A. Flannery, Patricia R. Peter, Cheryl A. Leone & Nina S. Stachenfeld. (2019) Compromised endothelial function in transgender men taking testosterone. Clinical Endocrinology 92:2, pages 138-144.
Crossref
Crossref
Anna E. Stanhewicz, Megan M. Wenner & Nina S. Stachenfeld. (2018) Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan. American Journal of Physiology-Heart and Circulatory Physiology 315:6, pages H1569-H1588.
Crossref
Crossref
Mark Paulos & Martin Miner. 2017. Male Sexual Dysfunction. Male Sexual Dysfunction
109
119
.
Martin Miner. 2015. Erectile Dysfunction in Hypertension and Cardiovascular Disease. Erectile Dysfunction in Hypertension and Cardiovascular Disease
145
158
.
Håkan Olsson, Rikard Sandström, Anders Neijber, Dario Carrara & Lars Grundemar. (2014) Pharmacokinetics and bioavailability of a new testosterone gel formulation in comparison to Testogel® in healthy men. Clinical Pharmacology in Drug Development 3:5, pages 358-364.
Crossref
Crossref
Aminu K. Bello, Peter Stenvinkel, Meng Lin, Brenda Hemmelgarn, Ravi Thadhani, Scott Klarenbach, Christopher Chan, Deborah Zimmerman, George Cembrowski, Giovanni Strippoli, Juan-Jesus Carrero & Marcello Tonelli. (2014) Serum Testosterone Levels and Clinical Outcomes in Male Hemodialysis Patients. American Journal of Kidney Diseases 63:2, pages 268-275.
Crossref
Crossref
Charles D. Ciccone. 2012. Geriatric Physical Therapy. Geriatric Physical Therapy
38
63
.
Mohit Khera, Rajib K. Bhattacharya, Gary Blick, Harvey Kushner, Dat Nguyen & Martin M. Miner. (2011) Changes in Prostate Specific Antigen in Hypogonadal Men After 12 Months of Testosterone Replacement Therapy: Support for the Prostate Saturation Theory. Journal of Urology 186:3, pages 1005-1011.
Crossref
Crossref
Elizabeth Steels, Amanda Rao & Luis Vitetta. (2011)
Physiological Aspects of Male Libido Enhanced by Standardized
Trigonella foenum‐graecum
Extract and Mineral Formulation
. Phytotherapy Research 25:9, pages 1294-1300.
Crossref
Crossref
Firoozeh Salehzadeh, Anna Rune, Megan Osler & Lubna Al-Khalili. (2011) Testosterone or 17β-estradiol exposure reveals sex-specific effects on glucose and lipid metabolism in human myotubes. Journal of Endocrinology 210:2, pages 219-229.
Crossref
Crossref
K. L. Billups, M. M. Miner, A. S. Wierzbicki & G. Jackson. (2011) Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk. International Journal of Clinical Practice 65:2, pages 134-147.
Crossref
Crossref
G. Jackson. (2010) Testosterone deficiency syndrome (TDS) and the heart. European Heart Journal 31:12, pages 1436-1437.
Crossref
Crossref
R. Sadovsky, G. B. Brock, S. W. Gutkin & S. Sorsaburu. (2009) Toward a new ‘EPOCH’: optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction. International Journal of Clinical Practice 63:8, pages 1214-1230.
Crossref
Crossref
. (2009) Current World Literature. Current Opinion in Obstetrics & Gynecology 21:4, pages 353-363.
Crossref
Crossref
Harry W. Herr. (2009) GOAT GLANDS REJUVENATED. BJU International 104:1, pages 2-4.
Crossref
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:3.
Crossref
Crossref
U. Paasch, H.-J. Glander & J.-U. Stolzenburg. (2009) Andrologische TestosteronersatztherapieAndrological testosterone replacement therapy. Der Urologe 48:1, pages 79-87.
Crossref
Crossref